199 related articles for article (PubMed ID: 3892339)
1. Insulin antibodies--do they matter?
Walford S
Neth J Med; 1985; 28 Suppl 1():47-9. PubMed ID: 3892339
[No Abstract] [Full Text] [Related]
2. [Immunologic problems in diabetes mellitus].
Federlin K
Wien Med Wochenschr; 1979 Dec; 129(23):661-6. PubMed ID: 120635
[No Abstract] [Full Text] [Related]
3. Immunologic implications of insulin delivery and the role of immune complexes in diabetic sequelae.
Charles MA; Ong K; Slater L; Golden M; Arquilla ER
Diabetes Care; 1982; 5 Suppl 1():88-92. PubMed ID: 6765123
[TBL] [Abstract][Full Text] [Related]
4. [Current trends in the treatment of diabetes mellitus].
Jacobelli A
Clin Ter; 1984 Aug; 110(3):277-81. PubMed ID: 6237866
[No Abstract] [Full Text] [Related]
5. Immunologic reactivity to insulin: animal models and clinical syndromes.
Rosenwasser LJ
Clin Immunol Rev; 1981-1982; 1(2):311-35. PubMed ID: 6762277
[TBL] [Abstract][Full Text] [Related]
6. Immune complexes in type I diabetics with persistent islet cell antibodies.
Irvine WJ; Di Mario U; Guy K; Borsey DQ
J Clin Lab Immunol; 1980 Sep; 4(2):87-9. PubMed ID: 7003148
[TBL] [Abstract][Full Text] [Related]
7. Immune complexes in newly diagnosed insulin-dependent (type I) diabetics.
Irvine WJ; Di Mario U; Guy K; Feek CM; Gray RS; Duncan LJ
J Clin Lab Immunol; 1978 Nov; 1(3):183-6. PubMed ID: 387959
[TBL] [Abstract][Full Text] [Related]
8. [Antibodies against endocrine pancreas in insulin-dependent diabetes].
Lernmark A
Lakartidningen; 1980 Jul; 77(30-31):2614-6. PubMed ID: 7003271
[No Abstract] [Full Text] [Related]
9. Elevated circulating proinsulin levels in insulin-requiring diabetic patients.
Block MB; Mako M; Steiner DF; Rubenstein AH
J Lab Clin Med; 1971 Nov; 78(5):811-2. PubMed ID: 5316079
[No Abstract] [Full Text] [Related]
10. [Is diabetes an autoimmune disease? The possible pathogenic significance of islet-cell auto-antibodies].
Dyrberg T
Ugeskr Laeger; 1982 Dec; 144(50):3723-7. PubMed ID: 6762744
[No Abstract] [Full Text] [Related]
11. [Actual problems of diabetes mellitus].
Balabolkin MI
Sov Med; 1989; (11):3-7. PubMed ID: 2697087
[No Abstract] [Full Text] [Related]
12. Immunogenicity of bovine, porcine and semisynthetic human insulin.
Venekamp WJ; van der Hooft JC; Jacobsen L; van Schaik CL
Neth J Med; 1985; 28 Suppl 1():57-8. PubMed ID: 3892343
[No Abstract] [Full Text] [Related]
13. [Significance of the preparative insulin chemistry for clinical diabetology].
Petrides P
Dtsch Med Wochenschr; 1973 Nov; 98(47):2256-8. PubMed ID: 4271376
[No Abstract] [Full Text] [Related]
14. [Experiences with monocomponent insulin treatment].
Korp W; Levett RE
Wien Klin Wochenschr; 1973 May; 85(18):326-30. PubMed ID: 4699490
[No Abstract] [Full Text] [Related]
15. [Autoimmunity in diabetes mellitus].
Vel'bri SK
Ter Arkh; 1972 Feb; 44(2):7-12. PubMed ID: 4114273
[No Abstract] [Full Text] [Related]
16. [Mechanisms of damage to the islands of Langerhans in type I diabetes].
Pozzilli P; Colletti F; Tarentini M
Minerva Endocrinol; 1986; 11(1):45-8. PubMed ID: 3528801
[No Abstract] [Full Text] [Related]
17. [The place of hog insulin in treatment of diabes].
Laurent C
Diabete; 1969; 17(2):107-13. PubMed ID: 5408009
[No Abstract] [Full Text] [Related]
18. Soluble immune complexes in the sera of newly diagnosed insulin-dependent diabetics and in treated diabetics.
Irvine WJ; Al-Khateeb SF; Di Mario U; Feek CM; Gray RS; Edmond B; Duncan LJ
Clin Exp Immunol; 1977 Oct; 30(1):16-21. PubMed ID: 606435
[TBL] [Abstract][Full Text] [Related]
19. [Auto-immunity and insulin-dependent diabetes].
Vialettes B; Beaume D; Vague P
Diabete Metab; 1982 Dec; 8(4):349-55. PubMed ID: 6761189
[TBL] [Abstract][Full Text] [Related]
20. Islet cell antibodies in diabetes.
Brogren CH; Lernmark A
Clin Endocrinol Metab; 1982 Jul; 11(2):409-30. PubMed ID: 6754163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
